Latest Breaking News On - Chroma medicine inc - Page 1 : vimarsana.com

Chroma Medicine Presents Preclinical In Vivo Data Showing Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2023 AHA Scientific Sessions

Chroma Medicine Presents Preclinical In Vivo Data Showing Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2023 AHA Scientific Sessions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrederic tremblayCatherine stehman breenVic myerA single administrationChroma medicine incAmerican heart associationHeart associationScientific sessionsChief scientificChief executiveSingle administrationEpigenetic editor targeting humanVice presidentVivo programsLate breaking basic science abstract

Chroma Medicine Strengthens Leadership with the Appointment of Biotech Business Leader Michael A Kelly to its Board of Directors

/PRNewswire/ Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the addition.

United statesCatherine stehman breenMichaela kellyFloridaam universityBusiness administrationAmicus therapeuticsInternational commercial operationsCouncil of advisorsMonsanto life sciencesGlobal incChroma medicine incGlobal business servicesNutrasweet kelco companySentry hill partnersChroma medicineChief executive officer

Chroma Medicine Presents Data Showing Specific and Durable HBV Silencing with Epigenetic Editors at the HBV International Meeting 2023

Chroma Medicine Presents Data Showing Specific and Durable HBV Silencing with Epigenetic Editors at the HBV International Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesYesseinia anglero rodriguezVic myerInternational meetingChroma medicine incPrincipal scientistPoster session

Sangamo Therapeutics and Chroma Medicine Announce Option and License Agreement to Evaluate and Develop Zinc Finger Proteins for Epigenetic Editing

Sangamo Therapeutics, Inc. , a clinical-stage genomic medicine company and Chroma Medicine, Inc. , a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced.

Sangamo zfpsJason fontenotVic myerExchange commissionSangamo therapeutics incChroma medicine incSangamo therapeuticsChroma medicineChief scientific officerAnnual reportQuarterly report

Sangamo Therapeutics, Inc : Sangamo Therapeutics and Chroma Medicine Announce Option and License Agreement to Evaluate and Develop Zinc Finger Proteins for Epigenetic Editing

Sangamo Therapeutics, Inc : Sangamo Therapeutics and Chroma Medicine Announce Option and License Agreement to Evaluate and Develop Zinc Finger Proteins for Epigenetic Editing
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Sangamo zfpsVic myerLouise wilkieJason fontenotVerge scientific communicationsSangamo therapeutics incChroma medicine incExchange commissionSangamo therapeuticsChroma medicineChief scientific officerAnnual reportQuarterly reportRelations media inquiriesScientific communicationsDie experten